Sign in
4

Changes in Ownership

Anebulo Pharmaceuticals, Inc. Filed Acc 0001209191-22-052187

Options or other derivatives

  • Director acquired 30,425 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Lin Kenneth Director 2022-04-21 Grant or award · Stock Option (right to buy) +30,425 30,425 D: show line 1 in the form
Loading xslF345X03/doc4.xml…